SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults : A Scientific Statement From the American Heart Association
Coronavirus disease 2019 (COVID-19) resulted in a global pandemic and has overwhelmed health care systems worldwide. In this scientific statement, we describe the epidemiology, pathophysiology, clinical presentations, treatment, and outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome in children and young adults with a focus on cardiovascular manifestations and complications. We review current knowledge about the health consequences of this illness in children and young adults with congenital and acquired heart disease, the public health burden and health disparities of this infection in these populations, and vaccine-associated myocarditis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:145 |
|---|---|
| Enthalten in: |
Circulation - 145(2022), 19 vom: 10. Mai, Seite e1037-e1052 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jone, Pei-Ni [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
AHA Scientific Statements |
|---|
| Anmerkungen: |
Date Completed 11.05.2022 Date Revised 14.06.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1161/CIR.0000000000001064 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM339297964 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM339297964 | ||
| 003 | DE-627 | ||
| 005 | 20231226002600.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIR.0000000000001064 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1130.xml |
| 035 | |a (DE-627)NLM339297964 | ||
| 035 | |a (NLM)35400169 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jone, Pei-Ni |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults |b A Scientific Statement From the American Heart Association |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.05.2022 | ||
| 500 | |a Date Revised 14.06.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Coronavirus disease 2019 (COVID-19) resulted in a global pandemic and has overwhelmed health care systems worldwide. In this scientific statement, we describe the epidemiology, pathophysiology, clinical presentations, treatment, and outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome in children and young adults with a focus on cardiovascular manifestations and complications. We review current knowledge about the health consequences of this illness in children and young adults with congenital and acquired heart disease, the public health burden and health disparities of this infection in these populations, and vaccine-associated myocarditis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a AHA Scientific Statements | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a child | |
| 650 | 4 | |a multisystem inflammatory syndrome in children | |
| 650 | 4 | |a treatment outcome | |
| 650 | 4 | |a young adult | |
| 700 | 1 | |a John, Anitha |e verfasserin |4 aut | |
| 700 | 1 | |a Oster, Matthew E |e verfasserin |4 aut | |
| 700 | 1 | |a Allen, Kiona |e verfasserin |4 aut | |
| 700 | 1 | |a Tremoulet, Adrianna H |e verfasserin |4 aut | |
| 700 | 1 | |a Saarel, Elizabeth V |e verfasserin |4 aut | |
| 700 | 1 | |a Lambert, Linda M |e verfasserin |4 aut | |
| 700 | 1 | |a Miyamoto, Shelley D |e verfasserin |4 aut | |
| 700 | 1 | |a de Ferranti, Sarah D |e verfasserin |4 aut | |
| 700 | 0 | |a American Heart Association Leadership Committee and Congenital Cardiac Defects Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Hypertension, and Council on Peripheral Vascular Disease |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation |d 1950 |g 145(2022), 19 vom: 10. Mai, Seite e1037-e1052 |w (DE-627)NLM000039020 |x 1524-4539 |7 nnns |
| 773 | 1 | 8 | |g volume:145 |g year:2022 |g number:19 |g day:10 |g month:05 |g pages:e1037-e1052 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/CIR.0000000000001064 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 145 |j 2022 |e 19 |b 10 |c 05 |h e1037-e1052 | ||